Relationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients

Journal of Zhejiang University: Science B

Volumn 11, Issue 4, 2010, Pages 249-257

  Kimak, Elzbieta ^a   Hałabiś, Magdalena ^a   Baranowicz Ga̧szczyk, Iwona ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

High density lipoprotein particle; Lipid; Lipoprotein; Renal transplantation; Triglyceride rich lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT CONTENT; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; KIDNEY TRANSPLANTATION; LIPID ANALYSIS; LIPID COMPOSITION; LIPID TRANSPORT; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL, HDL; HUMANS; HYPERTRIGLYCERIDEMIA; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, HDL; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; TRIGLYCERIDES;

EID: 77951098172     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1000012     Document Type: Article

References (28)

1. E.A. Brinton S. Eisenberg J.L. Breslow 1994 Human HDL cholesterol levels are determinate by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution Arteriosclerosis, Thrombosis, and Vascular Biology 14 5 707 720 1:CAS:528:DyaK2cXltVGhsrs%3D
2. D.C. Chan M.M. Chen M.M. Ooi G.F. Watts 2008 An ABC of apolipoprotein CIII: a clinically useful new cardiovascular risk factor? International Journal of Clinical Practice 62 5 799 809 10.1111/j.1742-1241.2007.01678.x 1:STN:280:DC%2BD1c3ltFWktQ%3D%3D 18201179 (Pubitemid 351533666)
3. J.H. Contois J.R. McNamara C.J. Lammi-Keefe P.W. Wilson T. Massov E.J. Schaefer 1996 Reference intervals for apolipoprotein AI with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study Clinical Chemistry 42 4 507 514 1:CAS:528:DyaK28Xit1Ontbg%3D 8605666 (Pubitemid 26111867)
4. B. Fellström 2001 Risk factors for and management of post-transplantation cardiovascular disease BioDrugs 15 4 261 278 10.2165/00063030-200115040-00006 11437691
5. W.T. Friedewald R.I. Levy D.S. Fredrickson 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge Clinical Chemistry 18 6 499 502 1:CAS:528:DyaE38Xkslagsbw%3D 4337382
6. R. Ghaznavi M. Zahmatkesh M. Kadhodaee M. Mahdavi-Mazdeh 2007 Cyclosporine effects on the antioxidant capacity of rat renal tissues Transplantation Proceedings 39 4 866 867 10.1016/j.transproceed.2007.02.039 1:CAS:528:DC%2BD2sXlvV2ruro%3D 17524835 (Pubitemid 46764839)
7. L. Gou M. Fu Y. Xu 2005 Alterations of HDL subclasses in endogenous hypertriglyceridemia American Heart Journal 150 5 1039 1045 10.1016/j.ahj.2005. 02.032 1:CAS:528:DC%2BD2MXht1Sru7rP 16290993 (Pubitemid 41607795)
8. K.E.I. Harchaoui B.A. Arsenault R. Franssen J.P. Després G.K. Hovingh E.S. Stroes J.D. Otvos N.J. Wareham J.J. Kastelein K.T. Khaw, et al. 2009 High-density lipoprotein particle size and concentration and coronary risk Annales of Internal Medicine 150 2 84 93
9. L. Jia S. Long M. Fu B. Yan Y. Tian Y. Xu L. Gou 2006 Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein ratio, and high-density lipoprotein subclasses Metabolism 55 9 1141 1148 10.1016/j.metabol.2006.04.004 1:CAS:528:DC%2BD28XotlCisbo%3D 16919530 (Pubitemid 44219052)
10. L. Jia X. Wu M. Fu Y. Xu Y. Tian H. Tian L. Tian 2007 Relationship between apolipoproteins and the alteration of HDL subclasses in hyperlipidemic subjects Clinica Chimica Acta 383 1-2 65 72 10.1016/j.cca.2007.04.017 1:CAS:528:DC%2BD2sXnsFWlsLs%3D (Pubitemid 47016445)
11. B.L. Kasiske H.A. Chakkera J. Roel 2000 Explained and unexplained ischemic heart disease risk after renal transplantation Journal of the American Society of Nephrology 11 9 1735 1743 1:STN:280:DC%2BD3M7ivVSjsQ%3D%3D 10966499
12. B. Kasiske F.G. Cosio J. Beto 2004 Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative American Journal of Transplantation 4 s7 13 53 10.1111/j.1600-6135.2004.0355.x 15027968
13. E. Kimak J. Solski I. Baranowicz-Ga̧szczyk A. Ksia̧żek 2006 A long-term study of dyslipidemia and dyslipoproteinemia in stable post-renal transplant patients Renal Failure 28 6 483 486 10.1080/ 08860220600778878 1:CAS:528:DC%2BD28Xpslahurs%3D 16928617 (Pubitemid 44277673)
14. E. Kimak A. Ksia̧żek J. Solski 2006 Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure Clinical Chemistry and Laboratory Medicine 44 1 64 69 10.1515/CCLM.2006.013 1:CAS:528:DC%2BD28XhtlWrs7c%3D 16375588 (Pubitemid 43010648)
15. E. Kimak A. Ksia̧żek I. Baranowicz-Ga̧szczyk J. Solski 2007 Disturbed lipids, lipoproteins and triglyceride rich-lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients Renal Failure 29 6 705 712 10.1080/08860220701460111 1:CAS:528:DC%2BD2sXps1GksLo%3D 17763166 (Pubitemid 47346998)
16. O. Miyazaki I. Fukamachi A. Mori H. Hashimoto M.A. Kawashiri A. Nohara T. Noguchi A. Inazu M. Yamagishi H. Mabuchi, et al. 2009 Formation of preβ1-HDL during lipolysis of triglyceride-rich lipoprotein Biochemical and Biophysical Research Communications 379 1 55 59 10.1016/j.bbrc.2008.11.146 1:CAS:528:DC%2BD1MXosVShug%3D%3D 19070596
17. National Kidney Foundation 2002 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification American Journal of Kidney Disease 39 Suppl.2 S1 S266
18. E.M.M. Ooi P. Hugh R. Barrett D.C. Chan G.F. Watts 2008 Apolipoprotein CIII: understanding an emerging cardiovascular risk factor Clinical Science 114 10 611 624 10.1042/CS20070308 1:CAS:528:DC%2BD1cXksF2mtrs%3D 18399797 (Pubitemid 351589061)
19. S. Rashid P.H.R. Barrett K.D. Uffelman T. Watanabe K. Adeli G.F. Lewis 2002 Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation Arteriosclerosis, Thrombosis, and Vascular Biology 22 3 483 491 10.1161/hq0302.105374 1:CAS:528:DC%2BD38XitFGgtrk%3D 11884294 (Pubitemid 34218758)
20. E.M. Rubin B.Y. Ishida S.M. Clift R.M. Kranss 1991 Expression of human apolipoprotein AI in transgenic mice results in reduced plasma levels of murine apolipoprotein AI and appearance of two new high density lipoprotein size subclasses PNAS 88 2 434 438 10.1073/pnas.88.2.434 1:CAS:528:DyaK3MXhs1Wgur0%3D 1703299
21. V. Shivaswamy R.B. Stevens R. Zephier R.M. Zephi J. Sun G. Groggel J. Erickson J. Larsen 2008 Dyslipidemia can be controlled in diabetic as well as nondiabetic recipients after kidney transplant Transplantation 85 9 1270 1276 10.1097/TP.0b013e31816de3F6 1:CAS:528:DC%2BD1cXlslKhs7Y%3D 18475182 (Pubitemid 351670475)
22. W. Sui H. Zou G. Zou Q. Yan H. Chen W. Che S. Xie 2008 Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation Transplant Immunology 20 1-2 95 98 10.1016/j.trim.2008.07.003 1:CAS:528:DC%2BD1cXhtlyksr7I 18703143
23. L. Tian X. Wu M. Fu Y. Qin Y. Xu L. Jia 2008 Relationship between plasma apolipoproteinB concentrations, apolipoproteinB/apolipoproteinA-I and HDL subclasses distribution Clinica Chimica Acta 388 1-2 148 155 10.1016/j.cca.2007.10.028 1:CAS:528:DC%2BD2sXhsVOltLvL (Pubitemid 350266583)
24. L. Tian J. Wu M. Fu Y. Xu L. Jia 2009 Relationship between apolipoprotein CIII concentrations and high-density lipoprotein subclass distribution Metabolism 58 5 668 674 10.1016/j.metabol.2009.01.007 1:CAS:528: DC%2BD1MXkslOkur8%3D 19375590
25. K.H. Tseng 2006 Standards of medical care in diabetes-2006: response to the American diabetes Diabetes Care 29 11 2563 2565 10.2337/dc06-0805 17065711 (Pubitemid 44912273)
26. L. Wang R. Gill T. Pedersen L.J. Higgins J.W. Newman J.C. Rutledge 2009 Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation Journal of Lipid Research 50 2 204 213 10.1194/jlr.M700505-JLR200 1:CAS:528:DC%2BD1MXhsVCmsb4%3D 18812596
27. K.M. Wissing D. Abramowicz N. Broders P. Vereerstraeten 2000 Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection Transplantation 70 3 464 472 10.1097/00007890-200008150-00012 1:STN:280:DC%2BD3cvhsFyrsg%3D%3D 10949188
28. Y. Yang B. Yan M. Fu Y. Xu Y. Tian 2005 Relationship between plasma lipid concentrations and HDL subclasses Clinica Chimica Acta 354 1-2 49 58 10.1016/j.cccn.2004.11.015 1:CAS:528:DC%2BD2MXhvVClsbY%3D (Pubitemid 40320673)